Due to the controlled negative pressure it creates at the wound site, it removes infection and exudate, allowing the wounds to heal in a shorter time. By shortening the healing time, it reduces the hospitalization time of patients, thus providing an economic advantage.
It is a new and innovative hemostatic agent designed to stop bleeding on contact and arterial bleeding within seconds. It is composed of agar and bovine factor proteins: II, VII, IX and X and acts as a catalyst in the clot formation process. This patented one-component system can overcome any bleeding situation with the potential to save many lives. When seconds count, it can make the difference that gives the patient the greatest opportunity for survival and tissue preservation.